| Application number | Title of the application | Filing Date | Status |
|---|
| 09/706337 | Methods for depleting and isolating alloreactive and antigen-reactive T cells from hematopoietic donor cells | Nov 2, 2000 | Abandoned |
Array
(
[id] => 803045
[patent_doc_number] => 07422748
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-09
[patent_title] => 'Vaccine composition of surfactants as adjuvant of immunity'
[patent_app_type] => utility
[patent_app_number] => 09/698121
[patent_app_country] => US
[patent_app_date] => 2000-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4003
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/422/07422748.pdf
[firstpage_image] =>[orig_patent_app_number] => 09698121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/698121 | Vaccine composition of surfactants as adjuvant of immunity | Oct 29, 2000 | Issued |
| 09/622253 | Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg | Oct 9, 2000 | Abandoned |
Array
(
[id] => 1593901
[patent_doc_number] => 06491894
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same'
[patent_app_type] => B1
[patent_app_number] => 09/659786
[patent_app_country] => US
[patent_app_date] => 2000-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 49
[patent_no_of_words] => 45987
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/491/06491894.pdf
[firstpage_image] =>[orig_patent_app_number] => 09659786
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/659786 | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same | Sep 10, 2000 | Issued |
| 09/659103 | Water-soluble globulin concentrate for improving growth in animals | Sep 10, 2000 | Abandoned |
Array
(
[id] => 1370341
[patent_doc_number] => 06558672
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity'
[patent_app_type] => B1
[patent_app_number] => 09/657274
[patent_app_country] => US
[patent_app_date] => 2000-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 16362
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/558/06558672.pdf
[firstpage_image] =>[orig_patent_app_number] => 09657274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/657274 | Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity | Sep 6, 2000 | Issued |
Array
(
[id] => 1323242
[patent_doc_number] => 06602660
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Methods of detecting T-cell activation'
[patent_app_type] => B1
[patent_app_number] => 09/651265
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10808
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602660.pdf
[firstpage_image] =>[orig_patent_app_number] => 09651265
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/651265 | Methods of detecting T-cell activation | Aug 29, 2000 | Issued |
| 09/636251 | Methods of inducing immune tolerance using immunotoxins | Aug 9, 2000 | Abandoned |
| 09/555208 | Tolerance inducing combination of at least two endogenous antigens for treatment of sms, sle, iddm, etc. | Jul 25, 2000 | Abandoned |
| 09/616622 | Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor | Jul 13, 2000 | Abandoned |
Array
(
[id] => 1241074
[patent_doc_number] => 06682897
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Peptides derived from human heat protein 60 for treatment of diabetes, compositions, methods and kits'
[patent_app_type] => B1
[patent_app_number] => 09/613743
[patent_app_country] => US
[patent_app_date] => 2000-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 8542
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/682/06682897.pdf
[firstpage_image] =>[orig_patent_app_number] => 09613743
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/613743 | Peptides derived from human heat protein 60 for treatment of diabetes, compositions, methods and kits | Jul 10, 2000 | Issued |
| 09/614483 | Compositions and methods for generating monoclonal antibodies representative of a specific cell type | Jul 9, 2000 | Abandoned |
Array
(
[id] => 1426458
[patent_doc_number] => 06504013
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody'
[patent_app_type] => B1
[patent_app_number] => 09/592998
[patent_app_country] => US
[patent_app_date] => 2000-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 10572
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/504/06504013.pdf
[firstpage_image] =>[orig_patent_app_number] => 09592998
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/592998 | Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody | Jun 11, 2000 | Issued |
| 09/573797 | Immunotoxin fusion proteins and means for expression thereof | May 17, 2000 | Abandoned |
| 09/486242 | MONOCLONAL ANTIBODY 3-6-A SPECIFIC TO SURFACE OF DENDRITIC CELLS AMONG THE PERIPHERAL BLOOD LEUKOCYTES | May 16, 2000 | Abandoned |
Array
(
[id] => 6736218
[patent_doc_number] => 20030013853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Human aflatoxin B1 aldehyde reductase'
[patent_app_type] => new
[patent_app_number] => 09/573446
[patent_app_country] => US
[patent_app_date] => 2000-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19314
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013853.pdf
[firstpage_image] =>[orig_patent_app_number] => 09573446
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/573446 | Human aflatoxin B1 aldehyde reductase | May 15, 2000 | Abandoned |
Array
(
[id] => 6745089
[patent_doc_number] => 20030022272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Method of inducing an antigen-specific anticytotoxic cell'
[patent_app_type] => new
[patent_app_number] => 09/570910
[patent_app_country] => US
[patent_app_date] => 2000-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5408
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022272.pdf
[firstpage_image] =>[orig_patent_app_number] => 09570910
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/570910 | Method of inducing an antigen-specific anticytotoxic cell | May 14, 2000 | Abandoned |
Array
(
[id] => 701131
[patent_doc_number] => 07063847
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-20
[patent_title] => 'Compositions and methods for enhancing immune responses mediated by antigen-presenting cells'
[patent_app_type] => utility
[patent_app_number] => 09/566922
[patent_app_country] => US
[patent_app_date] => 2000-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19713
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/063/07063847.pdf
[firstpage_image] =>[orig_patent_app_number] => 09566922
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/566922 | Compositions and methods for enhancing immune responses mediated by antigen-presenting cells | May 4, 2000 | Issued |
Array
(
[id] => 4274403
[patent_doc_number] => 06281012
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Method of preparing suppressor T cells with allogeneic mesenchymal stem cells'
[patent_app_type] => 1
[patent_app_number] => 9/563768
[patent_app_country] => US
[patent_app_date] => 2000-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 4547
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281012.pdf
[firstpage_image] =>[orig_patent_app_number] => 563768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/563768 | Method of preparing suppressor T cells with allogeneic mesenchymal stem cells | Apr 30, 2000 | Issued |
Array
(
[id] => 488266
[patent_doc_number] => 07214380
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-08
[patent_title] => 'Adjuvant therapy'
[patent_app_type] => utility
[patent_app_number] => 09/561089
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 15668
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214380.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561089
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561089 | Adjuvant therapy | Apr 27, 2000 | Issued |
